Was 2023 Novartis AG's best revenue year?

No. Novartis AG's highest recorded revenue year was 2025 at $54.5B. In 2023, Novartis AG reported $47.8B.

What was Novartis AG's highest ever annual revenue?

Novartis AG's highest ever annual revenue was $54.5B recorded in fiscal year 2025.

Novartis AG

PharmaceuticalsFounded 1996

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Explore Novartis AG

Core profile pages, annual revenue records, and related research hubs for this company.

Novartis AG

PharmaceuticalsFounded 1996

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Annual Revenue

Novartis AG Revenue in 2023

Q: What was Novartis AG's revenue in 2023?

Novartis AG reported $47.8B in revenue for fiscal year 2023. Novartis posted $47.8 billion in FY2023 net sales, the year it completed the 100% spin-off of its Sandoz generics division on October 4 to become a pure-play innovator.

FY2023 Revenue

$47.8B

Source: Annual report / company filing

Novartis AG reported $47.8B in revenue for fiscal year 2023. In 2024, revenue increased to $50.3B.

Novartis posted $47.8 billion in FY2023 net sales, the year it completed the 100% spin-off of its Sandoz generics division on October 4 to become a pure-play innovator.

Revenue by Year

FY2025 FY2024 FY2023

Novartis AG Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2025	$54.5B	$14.0B	+8.3%
FY2024	$50.3B	—	+5.3%
FY2023	$47.8B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Next year →

FY2024: $50.3B

Explore Novartis AG

Core profile pages, annual revenue records, and related research hubs for this company.